|
5 Companies |
|
1 Product |
|
1 Product |
|
6 Mechanisms of Action |
|
0 Trials |
|
48 News |
|
- | bisoprolol / Generic mfg., propranolol / Generic mfg.
Trial completion: Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Apr 18, 2018
P4, N=150, Completed, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed
- | Trial completion, Phase classification, Enrollment change: EEG Characteristics in Youth POTS and/or Syncope (clinicaltrials.gov) - Mar 27, 2018
P, N=80, Completed, Sponsor: Nationwide Children's Hospital
Active, not recruiting --> Completed Recruiting --> Completed | Phase classification: PN/A --> P | N=200 --> 80
- | Trial completion, Enrollment change, Trial primary completion date: The Renin-Aldosterone Axis in Postural Tachycardia Syndrome (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=35, Completed, Sponsor: Vanderbilt University Medical Center
Recruiting --> Completed | Phase classification: PN/A --> P | N=200 --> 80 Recruiting --> Completed | N=18 --> 35 | Trial primary completion date: Apr 2011 --> Dec 2012
- | Trial completion, Enrollment change, Trial primary completion date: Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea (clinicaltrials.gov) - Aug 14, 2017
P=N/A, N=19, Completed, Sponsor: Medical College of Wisconsin
Recruiting --> Completed | N=18 --> 35 | Trial primary completion date: Apr 2011 --> Dec 2012 Active, not recruiting --> Completed | N=50 --> 19 | Trial primary completion date: Jun 2018 --> Sep 2016
- | Trial completion: Objective Sleep Disturbances in Orthostatic Intolerance (clinicaltrials.gov) - Mar 27, 2017
P=N/A, N=100, Completed, Sponsor: Satish R. Raj
Active, not recruiting --> Completed | N=50 --> 19 | Trial primary completion date: Jun 2018 --> Sep 2016 Active, not recruiting --> Completed
- Trial completion, Enrollment change: Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients (clinicaltrials.gov) - Jan 31, 2017
P=N/A, N=20, Completed, Sponsor: Nationwide Children's Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=40 --> 20
- Trial primary completion date: EEG Characteristics in Youth POTS and/or Syncope (clinicaltrials.gov) - Jan 31, 2017
P=N/A, N=200, Recruiting, Sponsor: Nationwide Children's Hospital
Recruiting --> Completed | N=40 --> 20 Trial primary completion date: May 2016 --> May 2017
- Trial completion: Qualitative Sweat Distribution During Tilt Table Procedure (clinicaltrials.gov) - Jan 31, 2017
P=N/A, N=95, Completed, Sponsor: Nationwide Children's Hospital
Trial primary completion date: May 2016 --> May 2017 Recruiting --> Completed
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Enrollment change: CFS&ANS: Autonomic Nervous System and Chronic Fatigue Syndrome (clinicaltrials.gov) - Jan 18, 2017
P1, N=170, Completed, Sponsor: Vanderbilt University
Recruiting --> Completed N=58 --> 170
- Trial completion, Enrollment change: Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome (clinicaltrials.gov) - Jan 18, 2017
P=N/A, N=26, Completed, Sponsor: Vanderbilt University Medical Center
N=58 --> 170 Active, not recruiting --> Completed | N=57 --> 26
- Phase classification: High Sodium Diet and External Abdominal Compression in POTS (clinicaltrials.gov) - Jan 18, 2017
P1, N=13, Terminated, Sponsor: Vanderbilt University
Active, not recruiting --> Completed | N=57 --> 26 Phase classification: P=N/A --> P1
- Enrollment change, Trial termination: High Sodium Diet and External Abdominal Compression in POTS (clinicaltrials.gov) - Jan 17, 2017
P=N/A, N=4, Terminated, Sponsor: Vanderbilt University
Phase classification: P=N/A --> P1 N=20 --> 4 | Recruiting --> Terminated; Not enough volunteer recruited before funding could be secured.
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Trial completion, Enrollment change, Trial primary completion date: CFS&ANS: Autonomic Nervous System and Chronic Fatigue Syndrome (clinicaltrials.gov) - Jan 17, 2017
P1, N=58, Completed, Sponsor: Vanderbilt University
N=20 --> 4 | Recruiting --> Terminated; Not enough volunteer recruited before funding could be secured. Active, not recruiting --> Completed | N=80 --> 58 | Trial primary completion date: Jul 2017 --> Jan 2017
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Phase classification: CFS&ANS: Autonomic Nervous System and Chronic Fatigue Syndrome (clinicaltrials.gov) - Nov 22, 2016
P1, N=80, Active, not recruiting, Sponsor: Vanderbilt University
Active, not recruiting --> Completed | N=80 --> 58 | Trial primary completion date: Jul 2017 --> Jan 2017 Phase classification: P=N/A --> P1
- Trial primary completion date: Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea (clinicaltrials.gov) - Jul 23, 2016
P=N/A, N=50, Active, not recruiting, Sponsor: Medical College of Wisconsin
Phase classification: P=N/A --> P1 Trial primary completion date: Jun 2016 --> Jun 2018
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Trial primary completion date: CFS&ANS: Autonomic Nervous System and Chronic Fatigue Syndrome (clinicaltrials.gov) - Apr 28, 2016
P=N/A, N=80, Active, not recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Jun 2016 --> Jun 2018 Trial primary completion date: Jul 2016 --> Jul 2017
- Enrollment closed: Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=57, Active, not recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Jul 2016 --> Jul 2017 Recruiting --> Active, not recruiting
- bisoprolol / Generic mfg., propranolol / Generic mfg.
Enrollment closed: Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Apr 15, 2016
P4, N=150, Active, not recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial primary completion date: High Sodium Diet and External Abdominal Compression in POTS (clinicaltrials.gov) - Jan 30, 2016
P=N/A, N=20, Recruiting, Sponsor: Vanderbilt University
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2015 --> Dec 2016
- Venofer (iron sucrose complex) / Daiichi Sankyo
Trial primary completion date: Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Jan 17, 2016
P1/2, N=30, Recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- Trial primary completion date: Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea (clinicaltrials.gov) - Sep 8, 2015
P=N/A, N=50, Active, not recruiting, Sponsor: Medical College of Wisconsin
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jun 2014 --> Jun 2016
- propranolol / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Effect of Exercise in OI (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=12, Completed, Sponsor: Vanderbilt University
Trial primary completion date: Jun 2014 --> Jun 2016 Active, not recruiting --> Completed | N=20 --> 12 | Trial primary completion date: Sep 2016 --> May 2015
- Trial completion, Enrollment change, Trial primary completion date: Cognitive Dysfunction in Postural Tachycardia Syndrome (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=60, Completed, Sponsor: Vanderbilt University
Active, not recruiting --> Completed | N=20 --> 12 | Trial primary completion date: Sep 2016 --> May 2015 Active, not recruiting --> Completed | N=85 --> 60 | Trial primary completion date: Mar 2018 --> Jun 2015
- ||| bisoprolol / Generic mfg., propranolol / Generic mfg.
Enrollment change: Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Jun 11, 2015
P4, N=150, Recruiting, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed | N=85 --> 60 | Trial primary completion date: Mar 2018 --> Jun 2015 N=120 --> 150
- || bisoprolol / Generic mfg., propranolol / Generic mfg.
Trial primary completion date: Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Apr 18, 2015
P4, N=120, Recruiting, Sponsor: Seoul National University Hospital
N=120 --> 150 Trial primary completion date: Jul 2014 --> Dec 2015
- Venofer (iron sucrose complex) / Daiichi Sankyo
Trial primary completion date: Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Apr 14, 2015
P1/2, N=30, Recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Jul 2014 --> Dec 2015 Trial primary completion date: Jan 2015 --> Dec 2015
- Trial completion, Trial primary completion date: Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life (clinicaltrials.gov) - Apr 3, 2015
P=N/A, N=21, Completed, Sponsor: Genetic Disease Investigators
Trial primary completion date: Jan 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Oct 2011 --> Apr 2015
- propranolol / Generic mfg.
Trial primary completion date: Effect of Exercise in OI (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: Vanderbilt University
Recruiting --> Completed | Trial primary completion date: Oct 2011 --> Apr 2015 Trial primary completion date: Nov 2014 --> Sep 2016
- Trial primary completion date: Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients (clinicaltrials.gov) - Dec 30, 2014
P=N/A, N=40, Recruiting, Sponsor: Nationwide Children's Hospital
Trial primary completion date: Nov 2014 --> Sep 2016 Trial primary completion date: Feb 2015 --> Feb 2016
- Trial primary completion date: Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome (clinicaltrials.gov) - Dec 24, 2014
P=N/A, N=57, Recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Feb 2015 --> Feb 2016 Trial primary completion date: Feb 2015 --> Feb 2017
- Trial primary completion date: Objective Sleep Disturbances in Orthostatic Intolerance (clinicaltrials.gov) - Dec 24, 2014
P=N/A, N=100, Active, not recruiting, Sponsor: Satish R. Raj
Trial primary completion date: Feb 2015 --> Feb 2017 Trial primary completion date: Dec 2014 --> Dec 2016
- Enrollment closed, Trial primary completion date: Cognitive Dysfunction in Postural Tachycardia Syndrome (clinicaltrials.gov) - Dec 24, 2014
P=N/A, N=85, Active, not recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Dec 2014 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Mar 2018
- | bisoprolol / Generic mfg., propranolol / Generic mfg.
New P4 trial: Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Jun 27, 2014
P4, N=120, Recruiting, Sponsor: Seoul National University Hospital
- bisoprolol / Generic mfg., propranolol / Generic mfg.
Enrollment open: Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Jun 27, 2014
P4, N=120, Recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Mar 2018 Not yet recruiting --> Recruiting
- Trial primary completion date: Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients (clinicaltrials.gov) - Jun 17, 2014
P=N/A, N=40, Recruiting, Sponsor: Nationwide Children's Hospital
Not yet recruiting --> Recruiting Trial primary completion date: Feb 2014 --> Feb 2015
- | NN1213 / Novo Nordisk
Trial completion: Hypnosis in Autonomic Function (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=93, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Trial primary completion date: Feb 2014 --> Feb 2015 No longer recruiting --> Completed
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Enrollment closed: CFS&ANS: Autonomic Nervous System and Chronic Fatigue Syndrome (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=80, Active, not recruiting, Sponsor: Vanderbilt University
No longer recruiting --> Completed Recruiting --> Active, not recruiting
- | Venofer (iron sucrose complex) / Daiichi Sankyo
New P1/2 trial: Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Nov 5, 2013
P1/2, N=30, Recruiting, Sponsor: Mayo Clinic
- | Venofer (iron sucrose complex) / Daiichi Sankyo
Enrollment open: Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) (clinicaltrials.gov) - Oct 30, 2013
P1/2, N=30, Recruiting, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- propranolol / Generic mfg.
Enrollment closed: Effect of Exercise in OI (clinicaltrials.gov) - May 23, 2013
P=N/A, N=20, Active, not recruiting, Sponsor: Vanderbilt University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Enrollment closed: Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects (clinicaltrials.gov) - Mar 26, 2013
P=N/A, N=48, Active, not recruiting, Sponsor: Wake Forest University Baptist Medical Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment change: Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration (clinicaltrials.gov) - Feb 13, 2013
P0, N=14, Completed, Sponsor: Vanderbilt University
Recruiting --> Active, not recruiting N=20 --> 14
- Trial completion: Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration (clinicaltrials.gov) - Feb 13, 2013
P0, N=14, Completed, Sponsor: Vanderbilt University
N=20 --> 14 Active, not recruiting --> Completed
- Clinical: High Sodium Diet and External Abdominal Compression in POTS (clinicaltrials.gov) - Jan 16, 2013
P=N/A, N=20, Recruiting, Sponsor: Vanderbilt University
- Enrollment closed: Objective Sleep Disturbances in Orthostatic Intolerance (clinicaltrials.gov) - Jan 6, 2013
P=N/A, N=100, Active, not recruiting, Sponsor: Satish R. Raj
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial termination: Dopamine in Orthostatic Tolerance (clinicaltrials.gov) - Jun 18, 2012
P=N/A, N=22, Terminated, Sponsor: Vanderbilt University
Recruiting --> Active, not recruiting Active, not recruiting --> Terminated; This study is being replaced by another protocol.
- Enrollment change: Dopamine in Orthostatic Tolerance (clinicaltrials.gov) - Jun 18, 2012
P=N/A, N=22, Terminated, Sponsor: Vanderbilt University
Active, not recruiting --> Terminated; This study is being replaced by another protocol. N=56 --> 22